Narcotic use in patients with Crohn's disease. Cross RK, Wilson KT, Binion DG (2005) Am J Gastroenterol 100: 2225-9 Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study. Chaugai S, Dickson AL, Shuey MM, Feng Q, Barker KA, Wei WQ, Luther JM, Stein CM, Chung CP (2019) Clin Pharmacol Ther 105: 703-709 Polypharmacy and Crohn's disease. Cross RK, Wilson KT, Binion DG (2005) Aliment Pharmacol Ther 21: 1211-6 Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. Morandi A, Vasilevskis E, Pandharipande PP, Girard TD, Solberg LM, Neal EB, Koestner T, Torres RE, Thompson JL, Shintani AK, Han JH, Schnelle JF, Fick DM, Ely EW, Kripalani S (2013) J Am Geriatr Soc 61: 1128-34 Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records. Oetjens MT, Denny JC, Ritchie MD, Gillani NB, Richardson DM, Restrepo NA, Pulley JM, Dilks HH, Basford MA, Bowton E, Masys DR, Wilke RA, Roden DM, Crawford DC (2013) Pharmacogenomics 14: 735-44
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.